Loading...
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis
Targeting the metastatic process is a critical pursuit in the treatment of malignant disease. There are currently no specific anti‐metastatic drugs approved for clinical use, despite metastasis being the leading cause of death for cancer patients. Targeting the Tie1 receptor was shown as a possible...
Saved in:
| Published in: | EMBO Mol Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7278564/ https://ncbi.nlm.nih.gov/pubmed/32406209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012355 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|